Zinc: Immune Gatekeeper, Hormone Modulator and DNA Repair Catalyst

Overview

Zinc ($Zn^{2+}$) is an indispensable transition metal serving as a catalytic, structural, and regulatory ion across more than three hundred distinct metalloenzymes. Within human physiology, this divalent cation orchestrates fundamental biological networks, acting simultaneously as a dynamic immune gatekeeper, a nuanced endocrine modulator, and a non-negotiable catalyst for genomic stability and DNA repair. Despite its profound systemic influence, the human body lacks a specialised storage organ for zinc, creating an absolute reliance on regular dietary intake and efficient gastrointestinal absorption—a challenge compounded in the UK population by high dietary phytate consumption from unrefined grains, which significantly chelates free ions and inhibits intestinal uptake via ZIP4 transporters.

At the cellular level, zinc’s structural integrity is exemplified by the "zinc finger" motif, a ubiquitous protein fold that stabilises tertiary structures through tetrahedral coordination with cysteine and histidine residues. This structural architecture is paramount for DNA recognition, transcriptional regulation, and chromatin remodelling. Furthermore, zinc operates as a critical structural and catalytic component of various DNA polymerases and mismatch repair enzymes, including O6-methylguanine-DNA methyltransferase (MGMT) and base excision repair (BER) glycosylases. Without adequate intracellular $Zn^{2+}$ saturation, the fidelity of DNA replication collapses, leaving the genome acutely vulnerable to oxidative mutagenesis, chromosomal aberrations, and premature cellular senescence—pathological hallmarks that accelerate systemic aging and oncogenesis.

Beyond genomic maintenance, zinc acts as a master regulator of both innate and adaptive immunity. Landmark clinical investigations indexed in PubMed demonstrate that intracellular free zinc concentrations directly modulate signal transduction cascades within leukocytes. Zinc deficiency impairs thymulin bioactivity, leading to thymic atrophy and a marked reduction in naive T-lymphocyte output. Concurrently, macrophage and neutrophil phagocytic capacity, natural killer (NK) cell cytotoxicity, and cytokine production become severely dysregulated. By acting as a physiological brake on phosphotyrosine phosphatases and protein kinase C, zinc prevents aberrant, chronic inflammatory cascades, mitigating the risk of a cytokine storm while simultaneously mounting a robust defense against viral and bacterial pathogens.

Endocrinologically, zinc exerts profound modulatory effects across the hypothalamic-pituitary-gonadal (HPG) and thyroid axes. The metal is heavily concentrated within the anterior pituitary and gonadal tissues, where it facilitates the synthesis, storage, and peripheral conversion of hormones. Research confirms that zinc status directly correlates with circulating free testosterone levels via aromatase inhibition and the upregulation of 17$\beta$-hydroxysteroid dehydrogenase. Furthermore, zinc is essential for the structural integrity of insulin crystals within pancreatic $\beta$-cells and acts as an intracellular second messenger in insulin signalling pathways, directly influencing peripheral glucose homeostasis and metabolic kinetics.

For advanced biological education platforms such as INNERSTANDIN, moving beyond reductionist nutritional paradigms requires a rigorous, mechanistic appreciation of zinc as a foundational molecular architect. Maintaining optimal cellular zinc homeostasis is not merely a strategy for general wellness; it is a physiological imperative for preserving genomic integrity, immunological resilience, and endocrine equilibrium across the human lifespan.

The Biology — How It Works

At the molecular level, zinc ($Zn^{2+}$) functions not merely as a passive structural cofactor, but as a master regulatory node governing over three hundred metalloenzymes and transcription factors. In the context of genomic stability and cellular homeostasis, zinc acts as a catalytic and structural pillar. As demonstrated in landmark toxicological and nutritional evaluations published in journals such as The Lancet, human zinc homeostasis is tightly regulated across cellular compartments by two opposing families of transporter proteins: the Zrt- and Irt-like proteins (ZIPs, which influx zinc into the cytoplasm) and Zinc Transporters (ZnT, which efflux zinc into organelles or extracellular space). This dynamic shuttling underpins zinc's primary role as an epigenetic modulator and genomic gatekeeper.

Consider its fundamental role as a structural motif in DNA repair pathways. Zinc fingers—specifically the $\text{C}2\text{H}2$ structural domains—rely on a central zinc ion coordinated by cysteine and histidine residues to fold into a finger-like configuration that binds specifically to DNA sequences and nuclear proteins. Without adequate intracellular $Zn^{2+}$ saturation, these tertiary structures destabilise, critically impairing the nucleotide excision repair (NER) and base excision repair (BER) machineries. Research indexed on PubMed highlights that zinc deficiency compromises the activity of poly (ADP-ribose) polymerases (PARPs), critical DNA nick-sensors that initiate cellular repair cascades. When zinc pools drop, single- and double-strand breaks accumulate, precipitating genomic instability, accelerated cellular senescence, and malignant transformation.

Beyond nuclear preservation, zinc orchestrates the immune response through intracellular signaling cascades. Within innate and adaptive immune cells, $Zn^{2+}$ operates as a second messenger. Phagocytic leukocytes—including neutrophils and macrophages—deploy dynamic intracellular zinc fluxes to regulate reactive oxygen species (ROS) generation via NADPH oxidase modulation. Furthermore, zinc is indispensable for the functional maturation of T-lymphocytes. It acts as a structural cofactor for thymulin, a thymic hormone essential for T-cell differentiation. Concurrently, intracellular free zinc downregulates nuclear factor kappa B (NF-$\kappa$B) signaling pathways, exerting a profound anti-inflammatory check on cytokine storms by inhibiting phosphodiesterases and preventing the over-activation of toll-like receptors (TLRs).

Endocrinologically, the mineral exerts an equally decisive influence on systemic hormone modulation. Zinc is heavily concentrated in the anterior pituitary and the testes, where it acts as a gatekeeper for steroidogenesis and gonadotropin-releasing hormone (GnRH) pulse generation. Mechanistic studies confirm that zinc inhibits aromatase activity, the enzymatic complex responsible for converting testosterone to oestradiol, thereby preserving androgen receptor sensitivity. Concurrently, within pancreatic $\beta$-cells, zinc is essential for the crystallisation, storage, and regulated exocytosis of insulin, binding within hexameric insulin structures to ensure precise glycemic regulation.

At INNERSTANDIN, we recognise that viewing zinc through the narrow lens of basic daily nutritional requirements ignores its vast, systemic enzymatic architecture. From stabilising chromatin architecture and catalysing DNA strand restitution to fine-tuning the immunological rheostat and steroidogenic output, zinc operates as an indispensable biochemical linchpin for human survival and physiological optimization.

Mechanisms at the Cellular Level

At the cellular and molecular tiers, zinc ($Zn^{2+}$) functions far beyond a passive structural cofactor, operating as a primary intracellular signalling hub, enzyme activator, and epigenetic regulator. Bioinorganic analyses confirm that approximately ten percent of the human proteome—spanning over 3,000 distinct proteins—requires zinc for thermodynamic stability and catalytic execution. Within the framework of INNERSTANDIN's biochemical architecture mapping, zinc's intracellular choreography is orchestrated by two opposing protein families: the ZIP (SLC39A) transporters, which influx $Zn^{2+}$ from the extracellular milieu or organellar lumens into the cytosol, and the ZnT (SLC30A) transporters, which sequester the cation into vesicles or export it across the plasma membrane. This tightly regulated spatial distribution establishes zinc as a dynamic second messenger, akin to calcium, modulating signal transduction pathways in real time.

In the nuclear compartment, zinc plays a non-negotiable role in genomic preservation and transcriptional regulation, primarily through the structural motif known as the zinc finger. These domains—typified by the classic $\text{Cys}2\text{His}2$ configuration—stabilise tertiary protein folds via tetrahedral coordination of a single $Zn^{2+}$ ion by conserved cysteine and histidine residues, allowing sequence-specific intercalation into major grooves of DNA. Seminal peer-reviewed data archived in PubMed demonstrate that zinc is indispensable for the catalytic activity of base excision repair (BER) and nucleotide excision repair (NER) enzymes, including poly(ADP-ribose) polymerases (PARP-1) and apurinic/apyrimidinic endonuclease 1 (APE1). Without adequate nuclear zinc stoichiometry, DNA damage response cascades stall, precipitating genomic instability, mutagenesis, and accelerated cellular senescence. Furthermore, zinc acts as an epigenetic gatekeeper by modulating the enzymatic activity of both histone deacetylases (HDACs) and histone acetyltransferases (HATs), directly altering chromatin architecture and transcriptional accessibility across inflammatory and metabolic gene loci.

At the plasma membrane and within cytosolic signaling networks, $Zn^{2+}$ exerts profound immunomodulatory and endocrine control. As demonstrated in toxicological and immunological literature referenced by major biomedical authorities, intracellular free zinc concentrations dictate the activation threshold of immune cells. Within T-lymphocytes, transient waves of cytosolic zinc—mobilised from intracellular stores via ZIP6 and ZIP8 upon T-cell receptor (TCR) engagement—are mandatory for downstream phosphorylation cascades, including Lck activation and interleukin-2 (IL-2) transcription. Conversely, chronic intracellular zinc depletion induces immune dysregulation by chronically upregulating nuclear factor kappa B (NF-$\kappa$B) pathways, driving unchecked pro-inflammatory cytokine cascades characteristic of inflammageing. Concurrently, endocrine signalling axes are modulated via zinc's interaction with the insulin-secreting vesicles of pancreatic $\beta$-cells, where it crystallises insulin into stable hexamers before exocytosis.

UK-based nutritional surveys, including the National Diet and Nutrition Survey (NDNS), consistently highlight sub-optimal dietary zinc intake across specific demographics, bypassing overt deficiency but inducing chronic, low-grade cellular dysfunction. At INNERSTANDIN, we emphasize that maintaining this delicate intracellular $Zn^{2+}$ equilibrium is not merely a matter of dietary repletion, but a biochemical imperative required to sustain enzymatic fidelity, epigenetic stability, and immunological resilience at the single-cell level.

Environmental Threats and Biological Disruptors

In the modern anthropogenic landscape, biological homeostasis is under constant siege from an array of environmental toxicants, endocrine disruptors, and nutritional antagonists. For INNERSTANDIN scholars examining the nexus of micronutrient sufficiency and systemic resilience, the depletion and functional inhibition of intracellular zinc represent critical vulnerabilities in human physiology. Industrial pollutants, agricultural residues, and dietary imbalances actively subvert zinc-dependent enzymatic pathways, compromising genomic stability, immunological competence, and hormonal regulation across populations.

A primary driver of this disruption is xenobiotic exposure, particularly heavy metals such as cadmium, lead, and mercury. According to toxicological studies indexed in PubMed, these divalent cations act as potent molecular mimics and competitive antagonists to zinc. Cadmium ($Cd^{2+}$), pervasive in industrial emissions and cigarette smoke, exhibits a significantly higher binding affinity for thiol-rich protein domains than zinc. Consequently, cadmium displaces zinc from vital metallothioneins and zinc-finger motifs—structural domains crucial for transcription factor binding and DNA repair enzymes like poly(ADP-ribose) polymerases (PARPs). This displacement inactivates the catalytic sites, leaving genomic DNA vulnerable to oxidative lesions and uncorrected strand breaks. Furthermore, high-affinity metal transporters such as divalent metal transporter 1 (DMT1) fail to discriminate effectively, inadvertently importing toxic loads while downregulating the cellular uptake of physiological zinc ($Zn^{2+}$).

Simultaneously, the modern food supply is compromised by widespread agronomic practices. Intensive farming methods and rising atmospheric carbon dioxide concentrations have precipitated 'nutrient dilution' in staple crops, markedly reducing bioavailable zinc in plant-derived foods. Compounding this dietary deficit is the ubiquity of dietary phytates—inositol hexakisphosphate—found in grains, legumes, and seeds. Phytates form insoluble chelation complexes with zinc within the gastrointestinal lumen, precipitating out of solution at physiological pH and rendering the mineral biologically inaccessible. In the UK, where plant-forward dietary shifts are increasingly promoted, the molar ratio of phytate to zinc frequently exceeds critical safety thresholds, blunting brush-border absorption via ZIP4 (Zrt- and Irt-like protein 4) transporters and engendering subclinical deficiency states that undermine systemic immune surveillance.

Beyond direct chemical antagonism and dietary sequestration, chronic low-grade systemic inflammation induced by environmental particulate matter ($PM_{2.5}$) and persistent organic pollutants (POPs) accelerates intracellular zinc attrition. During inflammatory cascades, the liver releases acute-phase reactants, most notably interleukin-6 (IL-6)-driven upregulation of hepcidin and redistribution proteins like metallothionein, which sequesters circulating zinc within hepatic and splenic stores. While an evolutionary defense mechanism designed to starve extracellular pathogens of vital micronutrients, prolonged environmental stress locks the host in a state of functional hypozincemia. This prevents immune cells—particularly T-lymphocytes and natural killer cells—from accessing the intracellular zinc pools required for signal transduction, interleukin-2 production, and thymulin activation.

Ultimately, these anthropogenic stressors converge to dismantle the body's primary biochemical defence network. Restoring biological integrity requires looking beyond simple RDA metrics, demanding a sophisticated understanding of how environmental toxification sabotages micronutrient utilization at the molecular level.

The Cascade: From Exposure to Disease

At the cellular level, sub-optimal zinc status initiates a silent, progressive pathophysiological cascade that ultimately underpins chronic systemic disease. When extracellular zinc availability drops—a state frequently exacerbated in the UK population by diets high in ultra-processed foods and phytate-rich grains—transmembrane transport mechanisms falter. Zinc is not stored in a dedicated reservoir; cells rely on a continuous supply managed by specialised ZIP (SLC39A) and ZnT (SLC30A) transporter proteins. As extracellular pools diminish, intracellular free zinc $\text{Zn}^{2+}$ pools contract, directly impairing the structural integrity of over 300 zinc-dependent metalloenzymes and transcription factors.

The initial manifestation of this deficit occurs within the immune apparatus. Zinc acts as a canonical second messenger in immune signalling; its depletion immediately dysregulates intracellular calcium flux, crippling the activation of protein kinase C (PKC) and downstream nuclear factor kappa B (NF-$\kappa$B) pathways in T-lymphocytes. Simultaneously, thymulin—a thymic hormone essential for T-cell differentiation—loses its biologically active conformation in the absence of bound zinc, leading to thymic involution and a skewed naive-to-memory T-cell ratio. Clinical observations published in journals such as The Lancet highlight that this immunosenescence-like phenotype heightens susceptibility to viral pathogens, establishing a baseline of chronic, low-grade pathogen-driven inflammation.

As the deficiency cascades from the immune system to endocrine axes, the loss of zinc's modulatory grip on hormone receptors becomes apparent. Intracellular zinc is required for the proper folding of zinc-finger domains within steroid hormone receptors, including androgen, oestrogen, and vitamin D receptors. In zinc insufficiency, hormone-receptor binding affinity plummets, inducing functional hormone resistance despite seemingly normal circulating serum levels. Concurrently, within pancreatic $\beta$-cells, zinc is indispensable for the crystallisation and storage of insulin within secretory vesicles via the ZnT8 transporter. Defective zinc handling impairs proinsulin cleavage and insulin exocytosis, directly driving dysglycaemia and accelerating the progression towards metabolic syndrome and type 2 diabetes mellitus—a major public health burden across the UK.

Compounding this metabolic and immunological deterioration is the catastrophic failure of genomic stability maintenance. Zinc serves as a structural cofactor for DNA polymerase alpha and various base excision repair (BER) and nucleotide excision repair (NER) enzymes, such as poly(ADP-ribose) polymerases (PARPs) and p53. Without adequate zinc coordination, these DNA surveillance proteins undergo conformational degradation, resulting in a compromised DNA damage response (DDR). Unrepaired single- and double-strand breaks accumulate, driving somatic mutations and genomic instability. Furthermore, zinc finger motifs in epigenetic regulators, including DNA methyltransferases and histone deacetylases (HDACs), misfold, causing aberrant epigenetic silencing of tumour suppressor genes and aberrant activation of pro-inflammatory oncogenic pathways.

At INNERSTANDIN, our critical appraisal of the literature reveals that this multi-system collapse—bridging immune paralysis, endocrine resistance, and genomic disintegration—demonstrates why marginal zinc deficiency is not a minor nutritional oversight, but a primary molecular driver of degenerative pathology.

What the Mainstream Narrative Omits

Standard nutritional guidance typically reduces zinc to a rudimentary checklist item: a dietary trace element required for wound healing, enzymatic function, and baseline immune defense. Yet, this reductionist mainstream narrative fundamentally omits the molecular reality of intracellular zinc homeostasis and its systemic governance over genomic stability and endocrinological signaling. Public health advisories issued by bodies such as the UK Scientific Advisory Committee on Nutrition (SACN) rely heavily on outdated, population-wide Reference Nutrient Intakes (RNIs) that fail to account for modern phytochemical-heavy diets rich in phytic acid, individual genetic variations in zinc transporters (such as ZIP and ZnT families), and the accelerating depletion of arable soils. Consequently, subclinical zinc deficiency remains an unrecognised systemic vulnerability across the British populace, compromising physiological resilience far below the threshold of overt clinical deficiency symptoms like acrodermatitis enteropathica.

At the molecular level, mainstream discourse overlooks zinc’s non-negotiable role as an epigenetic modulator and structural stabilizer of over two thousand transcription factors, colloquially known as 'zinc fingers'. As detailed in foundational biochemical literature indexed in PubMed, zinc is not merely a passive cofactor; it is an active secondary messenger operating within intracellular signalling cascades. It regulates immune homeostasis by directly inhibiting protein tyrosine phosphatases and modulating NF-$\kappa$B pathways, thereby reigning in chronic, low-grade systemic inflammation (inflammageing). Furthermore, standard medical frameworks rarely address zinc's indispensable role as a catalytic and structural component of the superoxide dismutase (Cu/Zn-SOD) antioxidant defense system, nor its absolute requirement for the enzymatic activation of matrix metalloproteinases and DNA polymerases integral to nucleotide excision repair.

When examining endocrine architecture, the reductionist paradigm completely glosses over zinc's intimate involvement in the hypothalamic-pituitary-gonadal (HPG) axis and thyroid hormone metabolism. Experimental models demonstrate that zinc depletion downregulates 5'-deiodinase activity—the selenoenzyme responsible for converting thyroxine ($T4$) to the biologically active triiodothyronine ($T3$)—mimicking primary hypothyroidism despite normal TSH levels. Concurrently, zinc acts as a competitive antagonist at NMDA receptor sites in the central nervous system and modulates free testosterone clearance rates, proving that its endocrine impact is systemic and profound. At INNERSTANDIN, we contend that moving past superficial nutritional paradigms requires acknowledging zinc for what it truly is: a master genomic stabilizer and physiological gatekeeper whose systemic optimization is foundational to human biological integrity.

The UK Context

Epidemiological data from the National Diet and Nutrition Survey (NDNS) reveal a persistent, under-reported vulnerability within the British population regarding micronutrient status, specifically concerning dietary zinc homeostasis. Despite the UK's diverse food supply, subclinical zinc insufficiency is prevalent across distinct demographics, notably among adolescents, the elderly, and individuals adhering to plant-based diets rich in phytic acid. Phytates—ubiquitous in whole grains and legumes consumed widely across the UK—act as potent chelating agents in the gastrointestinal tract, binding divalent zinc cations and severely impeding enterocyte absorption via ZIP4 transporters. This dietary barrier is compounded by the modern British diet's reliance on ultra-processed foods, which are notoriously stripped of bioavailable trace minerals.

At a cellular level, chronic marginal deficiency compromises the three core pillars of zinc biology outlined in contemporary peer-reviewed literature indexed on PubMed: innate/adaptive immunological surveillance, endocrine regulation, and genomic stability. Without optimal intracellular zinc pools, thymulin activation falters, blunting T-lymphocyte maturation and impairing natural killer cell cytotoxicity—an immunological deficit that leaves populations more susceptible to seasonal respiratory pathogens prevalent in the UK's temperate climate. Concurrently, endocrinological pathways are disrupted; zinc acts as a structural co-factor for the androgen receptor and plays a modulatory role in thyroid hormone conversion and insulin exocytosis. Data published in journals such as The Lancet underscore how marginal deficiencies exacerbate metabolic dysregulation and systemic low-grade inflammation.

Furthermore, genomic integrity is heavily dependent on adequate zinc thresholds. As a structural constituent of copper-zinc superoxide dismutase (Cu/Zn-SOD) and numerous DNA damage-response proteins—including zinc-finger nucleases and p53 stabilization complexes—zinc deficiency accelerates oxidative DNA damage and impairs poly(ADP-ribose) polymerase (PARP) enzymatic activity. At INNERSTANDIN, our analysis of UK public health metrics suggests that addressing this pervasive micronutrient gap requires a paradigm shift away from generalized dietary guidelines toward precision nutritional strategies. Recognising zinc not merely as a dietary supplement, but as a master biochemical regulator, is critical for mitigating chronic disease risk, preserving genomic fidelity, and optimising physiological resilience across the British populace.

Protective Measures and Recovery Protocols

Optimising zinc homeostasis requires a nuanced understanding of its pharmacokinetics, dietary matrices, and systemic utilisation, moving far beyond simplistic supplementation paradigms. At the cellular level, zinc absorption is heavily influenced by gastrointestinal transporters—primarily Zip4 (SLC39A4) for enterocyte uptake and ZnT1 (SLC30A1) for basolateral efflux into the portal circulation. However, this absorption axis is frequently compromised by dietary phytates found in unsprouted grains and legumes, which form insoluble chelates with divalent zinc cations, precipitating malabsorption. Clinical protocols established in nutritional immunology demonstrate that mitigating this antagonism necessitates both strategic food processing—such as enzymatic phytase activation via soaking or fermentation—and the selection of high-bioavailability chelates when clinical repletion is indicated. Research indexed in peer-reviewed literature, including evaluations published in The Lancet, indicates that amino acid chelates like zinc glycinate or organic salts such as zinc picolinate bypass competitive luminal inhibition far more effectively than inorganic oxides, ensuring optimal systemic delivery to peripheral tissues.

In the context of acute immune challenges or recovery phases from catabolic stress, precision dosing protocols are paramount to prevent iatrogenic imbalances. Excessive, unmonitored zinc supplementation acts as a potent competitive inhibitor of copper absorption via the upregulation of intestinal enterocyte metallothionein—a metal-binding protein that preferentially sequesters copper over zinc, ultimately precipitating secondary copper deficiency, myeloneuropathy, and dyslipidaemia. Therefore, evidence-led recovery protocols advocate for a physiological copper-to-zinc stoichiometric ratio, typically maintaining a 1:8 to 1:10 intake proportion. Furthermore, high-dose elemental regimens should be restricted to acute immunological windows—such as the early presentation of upper respiratory pathogen exposure, where high-affinity ionic zinc species exert direct virustatic effects by inhibiting viral RNA-dependent RNA polymerase activity within infected epithelia.

For chronic cellular optimisation, particularly regarding DNA repair kinetics and endocrine modulation, daily protocols must focus on steady-state saturation rather than pharmacological mega-dosing. Because zinc lacks a dedicated storage organelle within human physiology—relying instead on dynamic intracellular pools managed by the metallothionein-thionein system—consistent, bioavailable daily input is mandatory to maintain genomic stability. At INNERSTANDIN, our synthesis of clinical data emphasises that long-term recovery and protective measures must also account for individual genetic polymorphisms in zinc-regulating genes and systemic inflammatory loads, which can chronically deplete circulating serum zinc via interleukin-6-driven hepatic sequestration. Restoring and maintaining optimal zinc status thus requires an integrative methodology: eliminating anti-nutritional factors, matching chemical species to physiological demand, and balancing trace element synergy to protect genomic integrity, endocrine output, and immunological resilience against systemic decline.

Summary: Key Takeaways

Zinc operates as an indispensable biochemical pillar within human physiology, orchestrating over three hundred enzymatic reactions essential for genomic stability, immunological competence, and endocrine regulation. As substantiated by extensive peer-reviewed literature indexed in PubMed, this transition metal functions far beyond a standard dietary cofactor; it is a master regulator of cellular fate. At the molecular level, zinc fingers stabilise tertiary protein structures vital for high-fidelity DNA repair pathways—including base excision repair and double-strand break mechanisms—thereby mitigating mutagenesis and cellular senescence.

Immunologically, zinc acts as a critical gatekeeper, modulating intracellular second messengers, preserving mucosal barrier integrity, and orchestrating T-lymphocyte maturation and cytokine homeostasis. Endocrinologically, it exerts profound influence over steroidogenesis and thyroid axis function, modulating testosterone synthesis and peripheral thyroxine conversion. Within the rigorous framework of INNERSTANDIN, we recognise that suboptimal zinc status compromises systemic homeostasis, accelerating immunosenescence and genomic vulnerability. Clinical investigations in the UK highlight the prevalence of marginal deficiency, urging a paradigm shift toward precision nutritional science that prioritises intracellular zinc optimisation to safeguard long-term physiological resilience and metabolic integrity.